CDH Leads USD108m Series C for China’s IASO

CDH Baifu, an asset management platform under CDH Investments, led a USD108m Series C for IASO Biotherapeutics, a China-based clinical-stage biopharmaceutical company, with participation from CCB International, Everbright, Co-Stone Capital, CNCB Capital and Plaisance Capital, and follow-on from GL Ventures. Read more… Read More

Mid-Year 2021 Global Private Capital Industry Data & Analysis

GPC 1H 2021 data on fundraising, investment and exit activity across Asia, Latin America, Africa, CEE and the Middle East   Key data takeaways:   All major markets posted year-over-year gains in private capital deal value and deal count as the tech-fueled recovery from the pandemic continues. VC deals drove the… Read More



(default archive template)